New president appointed at Jubilant DraxImage Inc.
MONTREAL, May 28, 2012 /PRNewswire/ – We are pleased to announce the
appointment of Mr. Martyn Coombs as President, Jubilant DraxImage Inc.
at Montreal, Canada with effect from May 23, 2012.
Prior to joining Jubilant DraxImage, Mr. Coombs served as CEO of
Asterand PLC from 2007 to 2011.
During his term, he received an award from the Financial Times for the
top performing stock on the London Stock Exchange, out of over 2,000
Previously, he served in Japan for five years as Executive Vice
President of Nihon Medi-Physics Co. Ltd.
He has also held several executive positions with large international
organizations such as Amersham PLC and PerkinElmer Inc.
Mr. Coombs holds a degree in Mathematics and an MBA with distinction
from Warwick Business School.
About Jubilant DraxImage Inc.
Jubilant DraxImage Inc., a subsidiary of Jubilant Life Sciences,
develops, manufactures and markets diagnostic and therapeutic
radiopharmaceuticals for the global nuclear medicine marketplace.
Products includes a proprietary line of lyophilized Technetium-99m kits
(MAA, MDP, DTPA and Sestamibi).
Jubilant DraxImage Inc. is also a leading supplier of I-131
radiopharmaceuticals in North America, used for the diagnosis and
treatment of thyroid disorder and cancer.
Products in development comprises “next generation” Rubidium-82 and
Jubilant DraxImage Inc. products are exported worldwide, with regulatory
approval in USA, South America, parts of Europe and South-East Asia.
SOURCE Jubilant DraxImage Inc.
Image with caption: “Martyn Coombs, President of Jubilant DraxImage Inc. (CNW Group/Jubilant DraxImage Inc.)”. Image available at: http://photos.newswire.ca/images/download/20120528_C3061_PHOTO_EN_14223.jpg